INSPIRE: Raltegravir (Isentress) Pilot Study in Relapsing MS
A phase II baseline versus treatment study to determine the efficacy of raltegravir (ISENTRESS) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI - INSPIRE (Isentress Pilot Study in Relapsing MS) A phase II baseline versus treatment study to determine the efficacy of raltegravir (ISENTRESS) in p ...